Author

Yonghyo Kim

Korea Research Institute of Chemical TechnologyORCID 0000-0002-4447-9864Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:drug response / drug discovery· 2 Organism:human· 2 Assay:proteomics· 2 Approach:statistical model· 2 Research Focus:differential expression· 1 Research Focus:protein folding & dynamics· 1

Frequent Co-Authors

Aniel SáncheziD· 2 shared Áron BarthaiD· 2 shared Attila Marcell SzásziD· 2 shared Balázs GyőrffyiD· 2 shared Beáta SzeitziD· 2 shared D. M. PaliD· 2 shared David FenyöiD· 2 shared Elisabet Wieslander· 2 shared

Activity by Year

2024-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Aniel SánchezORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Identifying Ferroptosis Inducers, HDAC, and RTK Inhibitor Sensitivity in Melanoma Subtypes through Unbiased Drug Target Prediction

Indira Plá, Botond L. Szabolcs, Petra Nikolett Péter, Zsuzsanna Újfaludi, Yonghyo Kim, Peter L. Horvatovich, Aniel Sánchez, Krzysztof Pawłowski, Elisabet Wieslander, Magdalena Kuras, Jimmy Rodriguez Murillo, Jéssica de Siqueira Guedes, D. M. Pal, Anna A. Ascsillán, Lazaro Hiram Betancourt, , Lajos Vince Kemény

This paper identifies potential drug targets and predicts treatment efficacy and resistance in melanoma subtypes using proteogenomic data and drug sensitivity analysis.

International Journal of Dermatology · Dec 25, 2024Peer-reviewedCancer Biology

Predicting immune checkpoint therapy response in three independent metastatic melanoma cohorts

Letícia Szadai, Áron Bartha, Indira Plá, Alexandra I.T. Lakatos, D. Pal, A. S. Lengyel, Natália Pinto de Almeida, Ágnes Judit Jánosi, Fábio César Sousa Nogueira, Beáta Szeitz, Viktória Doma, Nicole Woldmar, Jéssica de Siqueira Guedes, Zsuzsanna Újfaludi, Zoltán Gábor Páhi, , Aniel Sánchez

The paper identifies six proteins that predict response to immune checkpoint therapy across three melanoma cohorts and correlate with patient survival.

Frontiers in Oncology · Jul 2, 2024Peer-reviewedCancer Biology